CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20,184 enrolled
Drug / intervention
Population-level screeningbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04746794
NCT04746794N/ACompleted
CompareCT.gov

Implementing the Moon: Getting Genomic Testing to the Public

University of Washington·interventional·Posted Feb 10, 2021·Updated Oct 9, 2024

In Brief

A clinical study evaluating Population-level screening for Genetic Predisposition. Completed, enrolled 20,184 participants across 2 sites.

Detailed Summary

The study intervention involves having patients complete a familial cancer risk assessment survey. Those who are found to be at high risk will be offered genetic testing for a panel of hereditary cancers. A "previvor" plan will be created to assist patients and their providers in completing the appropriate follow-up for those with a mutation identified.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGenetic Predisposition
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 10, 2021
Enrollment StartSep 25, 2020
Primary CompletionMay 31, 2023
Study CompletionJun 1, 2023
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 5.4 years ago

Interventions

Population-level screeningbehavioral

The study intervention involves having patients complete a familial cancer risk assessment survey. Those who are found to be at high risk will be offered genetic testing for a panel of hereditary cancers. A "previvor" plan will be created to assist patients and their providers in completing the appropriate follow-up for those with a mutation identified.